Pharmaceuticals South Africa

South Africa Contraceptive Innovations Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

South Africa Contraceptive Innovations Market Industry Trends and Forecast to 2034: Segmented by (Product, Hormone, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

South Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $28.9 Mn Placeholder estimate
Estimate 2025 $31.0 Mn 0.7% of the global market
Projected 2034 $57.4 Mn 85.4% Adds $26.4 Mn over 9 forecast years
CAGR 2025–2034 7.1% Faster than 23% of 186 Pharmaceuticals markets here
Key players 6 +1
  • South Africa is 0.66% of the global market.
  • In Africa, the largest is South Africa (this report) at $31.0 Mn.
  • Fastest growing: Egypt at 7.6% a year.
  • South Africa ranks 1st of 3 by size in Africa.

Market size projection

South Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$26.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Contraceptive Innovations Market market size by year, South Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $28.9 Mn — —
2025 (base) $31.0 Mn +$2.1 Mn —
2026 (forecast) $33.2 Mn +$2.2 Mn +7.1%
2027 (forecast) $35.5 Mn +$2.4 Mn +14.7%
2028 (forecast) $38.0 Mn +$2.5 Mn +22.8%
2029 (forecast) $40.7 Mn +$2.7 Mn +31.6%
2030 (forecast) $43.6 Mn +$2.9 Mn +40.9%
2031 (forecast) $46.7 Mn +$3.1 Mn +50.9%
2032 (forecast) $50.1 Mn +$3.3 Mn +61.6%
2033 (forecast) $53.6 Mn +$3.6 Mn +73.1%
2034 (forecast) $57.4 Mn +$3.8 Mn +85.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

South Africa Contraceptive Innovations Market Analysis at a glance
Market size, 2025$31.0 Mn placeholder estimate
Forecast, 2034$57.4 Mn placeholder estimate
Growth (CAGR), 2025–20347.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, hormone and end user (see all)
Key playersBayer AG, Organon, Perrigo Company plc, Evofem Biosciences, Mithra Pharmaceuticals and 1 more (see all)
Regulator in South AfricaSAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The South Africa Contraceptive Innovations Market Analysis Executive Summary

Contraceptive innovations are newer birth-control options such as hormone-free gels, long-acting injectables, vaginal rings and over-the-counter pills.

Key segments of the contraceptive Innovations market include product (Over-the-Counter Pills, Long-Acting Injectables and Vaginal Rings) and hormone (Hormonal and Non-Hormonal).

Bar chart: South Africa Contraceptive Innovations market size, 2024–2034, placeholder estimates. $28.9 Mn in 2024, $31.0 Mn in 2025 and $57.4 Mn in 2034, 7.1% CAGR.
South Africa Contraceptive Innovations market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

South Africa Contraceptive Innovations Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the contraceptive Innovations market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the contraceptive Innovations market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the contraceptive Innovations market.

Competitive Landscape for Contraceptive Innovations Market in South Africa

The contraceptive Innovations market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Contraceptive Innovations Market in South Africa

Contraceptive Innovations in South Africa: rules, payment and health figures

The South African Health Products Regulatory Authority (SAHPRA) registers medicines.⁠[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.⁠[2] Contraception use: 55% of married women 15–49 in 2016, the latest World Bank figure for South Africa.⁠[3]

[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[2] National Department of Health. Checked 14 Nov 2026.

[3] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 22 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for contraceptive Innovations. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Contraceptive Innovations right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Contraceptive Innovations in context

South Africa compared

  • Contraception use: 55% of married women 15–49 (2016). 4th highest of the 15 countries we cover in Africa.[1]
  • Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[2]
  • Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[3]

[1] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Contraceptive Innovations market in South Africa?
Placeholder estimate: about $31.0 Mn in 2025, rising to about $57.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Contraceptive Innovations market in South Africa growing?
Placeholder estimate: about 7.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Contraceptive Innovations market report cover?
The report splits the market by product (Over-the-Counter Pills, Long-Acting Injectables, Vaginal Rings, Non-Hormonal Gels and more), hormone (Hormonal, Non-Hormonal) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Contraceptive Innovations market?
Key players include Bayer AG, Organon, Perrigo Company plc, Evofem Biosciences, Mithra Pharmaceuticals and TherapeuticsMD.
What is driving the Contraceptive Innovations market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the contraceptive Innovations market. New products designed around women's biology and digital care are improving access.
Who regulates Contraceptive Innovations in South Africa?
The South African Health Products Regulatory Authority (SAHPRA) registers medicines. Source: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
How is healthcare paid for in South Africa?
Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone. Source: National Department of Health. Checked 14 Nov 2026.
What does World Bank report for South Africa?
Contraception use: 55% of married women 15–49 in 2016, the latest World Bank figure. Source: World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 22 Nov 2026.
How many people in South Africa are 65 or older?
6.9% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 22 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in South Africa

See all

Related on contraception and women's health

See the topic